{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T11:43:13Z","timestamp":1791027793662,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":1375,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["CELL-PID HEALTH-F5-2010-261387"],"award-info":[{"award-number":["CELL-PID HEALTH-F5-2010-261387"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["CLINIGENE LSHB-CT2006-018933"],"award-info":[{"award-number":["CLINIGENE LSHB-CT2006-018933"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["LSBH-CT-2004-005242"],"award-info":[{"award-number":["LSBH-CT-2004-005242"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1038\/mt.2012.23","type":"journal-article","created":{"date-parts":[[2012,2,28]],"date-time":"2012-02-28T13:34:03Z","timestamp":1330436043000},"page":"175-184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Preclinical Safety and Efficacy of Human CD34+ Cells Transduced With Lentiviral Vector for the Treatment of Wiskott-Aldrich Syndrome"],"prefix":"10.1016","volume":"21","author":[{"given":"Samantha","family":"Scaramuzza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Biasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ripamonti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C","family":"Castiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Loperfido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Draghici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raisa J","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Benedicenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Radrizzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Salomoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Ranzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia C","family":"Bartholomae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Vicenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Finocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robbert","family":"Bredius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marita","family":"Bosticardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christof","family":"von Kalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Montini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Biffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria G","family":"Roncarolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Naldini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Aiuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2012.23_bib1","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1182\/asheducation-2009.1.682","article-title":"Ten years of gene therapy for primary immune deficiencies","author":"Aiuti","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1038\/mt.2012.23_bib2","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/ni0610-457","article-title":"20 years of gene therapy for SCID","volume":"11","author":"Fischer","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1038\/mt.2012.23_bib3","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJMoa0805817","article-title":"Gene therapy for immunodeficiency due to adenosine deaminase deficiency","volume":"360","author":"Aiuti","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2012.23_bib4","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1056\/NEJMoa1000164","article-title":"Efficacy of gene therapy for X-linked severe combined immunodeficiency","volume":"363","author":"Hacein-Bey-Abina","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2012.23_bib5","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(04)17590-9","article-title":"Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector","volume":"364","author":"Gaspar","year":"2004","journal-title":"Lancet"},{"key":"10.1038\/mt.2012.23_bib6","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1172\/JCI35700","article-title":"Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1","volume":"118","author":"Hacein-Bey-Abina","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2012.23_bib7","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1172\/JCI35798","article-title":"Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients","volume":"118","author":"Howe","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2012.23_bib8","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nm.2088","article-title":"Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease","volume":"16","author":"Stein","year":"2010","journal-title":"Nat Med"},{"key":"10.1038\/mt.2012.23_bib9","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/nbt1216","article-title":"Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration","volume":"24","author":"Montini","year":"2006","journal-title":"Nat Biotechnol"},{"key":"10.1038\/mt.2012.23_bib10","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1171242","article-title":"Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy","volume":"326","author":"Cartier","year":"2009","journal-title":"Science"},{"key":"10.1038\/mt.2012.23_bib11","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature09328","article-title":"Transfusion independence and HMGA2 activation after gene therapy of human \u00df-thalassaemia","volume":"467","author":"Cavazzana-Calvo","year":"2010","journal-title":"Nature"},{"key":"10.1038\/mt.2012.23_bib12","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1182\/blood.V97.6.1598","article-title":"Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program","volume":"97","author":"Filipovich","year":"2001","journal-title":"Blood"},{"key":"10.1038\/mt.2012.23_bib13","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1182\/blood-2007-03-076679","article-title":"Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation","volume":"111","author":"Ozsahin","year":"2008","journal-title":"Blood"},{"key":"10.1038\/mt.2012.23_bib14","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1046\/j.1365-2141.2003.04310.x","article-title":"High incidence of lymphomas in a subgroup of Wiskott-Aldrich syndrome patients","volume":"121","author":"Shcherbina","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1038\/mt.2012.23_bib15","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jaci.2006.02.005","article-title":"The Wiskott-Aldrich syndrome","volume":"117","author":"Ochs","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1038\/mt.2012.23_bib16","first-page":"922","article-title":"Isolation of a novel gene mutated in Wiskott-Aldrich syndrome","volume":"79","author":"Derry","year":"1994","journal-title":"Cell"},{"key":"10.1038\/mt.2012.23_bib17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s12026-008-8086-1","article-title":"Recent advances in the biology of WASP and WIP","volume":"44","author":"Ramesh","year":"2009","journal-title":"Immunol Res"},{"key":"10.1038\/mt.2012.23_bib18","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1182\/blood-2008-12-115253","article-title":"Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome","volume":"113","author":"Bosticardo","year":"2009","journal-title":"Blood"},{"key":"10.1038\/mt.2012.23_bib19","first-page":"390","article-title":"Development of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome","volume":"8","author":"Boztug","year":"2006","journal-title":"Curr Opin Mol Ther"},{"key":"10.1038\/mt.2012.23_bib20","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1056\/NEJMoa1003548","article-title":"Stem-cell gene therapy for the Wiskott-Aldrich syndrome","volume":"363","author":"Boztug","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2012.23_bib21","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1021\/mp200132u","article-title":"Development of novel efficient SIN vectors with improved safety features for Wiskott-Aldrich syndrome stem cell based gene therapy","volume":"8","author":"Avedillo D\u00edez","year":"2011","journal-title":"Mol Pharm"},{"key":"10.1038\/mt.2012.23_bib22","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1089\/hum.2006.17.303","article-title":"Efficacy of gene therapy for Wiskott-Aldrich syndrome using a WAS promoter\/cDNA-containing lentiviral vector and nonlethal irradiation","volume":"17","author":"Dupr\u00e9","year":"2006","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2012.23_bib23","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2009.31","article-title":"Evidence for long-term efficacy and safety of gene therapy for Wiskott-Aldrich syndrome in preclinical models","volume":"17","author":"Marangoni","year":"2009","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.23_bib24","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.ymthe.2004.08.008","article-title":"Lentiviral vector-mediated gene transfer in T cells from Wiskott-Aldrich syndrome patients leads to functional correction","volume":"10","author":"Dupr\u00e9","year":"2004","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.23_bib25","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/sj.gt.3302863","article-title":"Lentiviral vectors targeting WASp expression to hematopoietic cells, efficiently transduce and correct cells from WAS patients","volume":"14","author":"Charrier","year":"2007","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2012.23_bib26","unstructured":"http:\/\/ec.europa.eu\/health\/human-use\/advanced-therapies\/index_en.htm"},{"key":"10.1038\/mt.2012.23_bib27","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1126\/science.1093933","article-title":"Development of a human adaptive immune system in cord blood cell-transplanted mice","volume":"304","author":"Traggiai","year":"2004","journal-title":"Science"},{"key":"10.1038\/mt.2012.23_bib28","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1525-0016(03)00002-9","article-title":"Transduced CD34+ cells from adrenoleukodystrophy patients with HIV-derived vector mediate long-term engraftment of NOD\/SCID mice","volume":"7","author":"Benhamida","year":"2003","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.23_bib29","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.ymthe.2004.08.014","article-title":"IL-3 or IL-7 increases ex vivo gene transfer efficiency in ADA-SCID BM CD34+ cells while maintaining in vivo lymphoid potential","volume":"10","author":"Ficara","year":"2004","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.23_bib30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/mt.2008.238","article-title":"Stem cell marking with promotor-deprived self-inactivating retroviral vectors does not lead to induced clonal imbalance","volume":"17","author":"Cornils","year":"2009","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.23_bib31","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/sj.mt.6300083","article-title":"Importance of murine study design for testing toxicity of retroviral vectors in support of phase I trials","volume":"15","author":"Will","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.23_bib32","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1128\/JVI.01089-06","article-title":"Prolonged adherence of human immunodeficiency virus-derived vector particles to hematopoietic target cells leads to secondary transduction in vitro and in vivo","volume":"81","author":"Pan","year":"2007","journal-title":"J Virol"},{"key":"10.1038\/mt.2012.23_bib33","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1182\/blood-2009-01-200733","article-title":"Wiskott-Aldrich syndrome protein is an effector of Kit signaling","volume":"114","author":"Mani","year":"2009","journal-title":"Blood"},{"key":"10.1038\/mt.2012.23_bib34","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1182\/blood-2005-02-0516","article-title":"Development of functional human blood and immune systems in NOD\/SCID\/IL2 receptor {gamma} chain(null) mice","volume":"106","author":"Ishikawa","year":"2005","journal-title":"Blood"},{"key":"10.1038\/mt.2012.23_bib35","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/10430340252769770","article-title":"Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors","volume":"13","author":"Follenzi","year":"2002","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2012.23_bib36","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1182\/blood-2007-01-068759","article-title":"Hot spots of retroviral integration in human CD34+ hematopoietic cells","volume":"110","author":"Cattoglio","year":"2007","journal-title":"Blood"},{"key":"10.1038\/mt.2012.23_bib37","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/jgm.1346","article-title":"Diverse genomic integration of a lentiviral vector developed for the treatment of Wiskott-Aldrich syndrome","volume":"11","author":"Mantovani","year":"2009","journal-title":"J Gene Med"},{"key":"10.1038\/mt.2012.23_bib38","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/mt.2009.179","article-title":"Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors","volume":"17","author":"Modlich","year":"2009","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.23_bib39","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1517\/14712598.8.2.181","article-title":"Development of lentiviral gene therapy for Wiskott Aldrich syndrome","volume":"8","author":"Galy","year":"2008","journal-title":"Expert Opin Biol Ther"},{"key":"10.1038\/mt.2012.23_bib40","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/ACI.0b013e32834c230c","article-title":"Gene therapy for the Wiskott-Aldrich syndrome","volume":"11","author":"Galy","year":"2011","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1038\/mt.2012.23_bib41","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1182\/blood.V90.7.2680","article-title":"Wiskott-Aldrich syndrome\/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype","volume":"90","author":"Zhu","year":"1997","journal-title":"Blood"},{"key":"10.1038\/mt.2012.23_bib42","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jaci.2009.11.034","article-title":"Revertant T lymphocytes in a patient with Wiskott-Aldrich syndrome: analysis of function and distribution in lymphoid organs","volume":"125","author":"Trifari","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1038\/mt.2012.23_bib43","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1089\/104303401750195935","article-title":"A new-generation stable inducible packaging cell line for lentiviral vectors","volume":"12","author":"Farson","year":"2001","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2012.23_bib44","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S1525-0016(03)00167-9","article-title":"Development of a sensitive assay for detection of replication-competent recombinant lentivirus in large-scale HIV-based vector preparations","volume":"8","author":"Escarpe","year":"2003","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.23_bib45","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/nmeth1103","article-title":"High-resolution insertion-site analysis by linear amplification-mediated PCR (LAM-PCR)","volume":"4","author":"Schmidt","year":"2007","journal-title":"Nat Methods"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616305731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616305731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T17:44:38Z","timestamp":1739209478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616305731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S1525001616305731"],"URL":"https:\/\/doi.org\/10.1038\/mt.2012.23","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical Safety and Efficacy of Human CD34+ Cells Transduced With Lentiviral Vector for the Treatment of Wiskott-Aldrich Syndrome","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/mt.2012.23","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The American Society of Gene & Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}